News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,186 Results
Type
Article (2594)
Company Profile (45)
Press Release (37546)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14200)
Career Advice (80)
Deals (2114)
Drug Delivery (9)
Drug Development (4146)
Employer Resources (10)
FDA (443)
Job Trends (783)
News (20291)
Policy (1061)
Tag
Academia (145)
Allergies (7)
Alliances (3493)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (446)
Artificial intelligence (31)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (477)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (324)
Cardiovascular disease (10)
Career advice (67)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (81)
Cervical cancer (2)
Clinical research (3438)
Collaboration (199)
Company closure (2)
Compensation (104)
COVID-19 (186)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (418)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (489)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (11)
Duchenne muscular dystrophy (40)
Earnings (4502)
Editorial (6)
Employer branding (1)
Employer resources (8)
Events (6404)
Executive appointments (134)
FDA (588)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (169)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (65)
Government (159)
Guidances (24)
Healthcare (709)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (198)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1005)
IRA (7)
Job creations (293)
Job search strategy (63)
JPM (5)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (217)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (315)
Medtech (316)
Mergers & acquisitions (1226)
Metabolic disorders (75)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (164)
NextGen: Class of 2026 (354)
Non-profit (157)
Now hiring (11)
Obesity (35)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (25)
Peanut (1)
People (5877)
Pharmaceutical (5)
Phase 1 (1474)
Phase 2 (1702)
Phase 3 (915)
Pipeline (390)
Policy (16)
Postmarket research (30)
Preclinical (640)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (62)
Real estate (425)
Recruiting (5)
Regulatory (918)
Reports (7)
Research institute (149)
Resumes & cover letters (10)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (498)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (53)
Venture capital (15)
Weight loss (23)
Women's health (10)
Worklife (1)
Date
Today (1)
Last 7 days (39)
Last 30 days (163)
Last 365 days (2416)
2026 (212)
2025 (2441)
2024 (2613)
2023 (2863)
2022 (3772)
2021 (4071)
2020 (3489)
2019 (2065)
2018 (1554)
2017 (1797)
2016 (1624)
2015 (1840)
2014 (1373)
2013 (1188)
2012 (1397)
2011 (1334)
2010 (1182)
Location
Africa (44)
Alabama (3)
Alaska (1)
Arizona (18)
Asia (1949)
Australia (309)
California (1601)
Canada (241)
China (80)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4028)
Florida (64)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (568)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (134)
New York (80)
North Carolina (131)
Northern California (781)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (652)
Tennessee (4)
Texas (153)
United States (3205)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,186 Results for "colossal biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning
November 5, 2025
·
6 min read
Press Releases
World-Leading Developmental Biologist Andrew Pask, Ph.D Joins Colossal Full-time as Chief Biology Officer
August 21, 2025
·
5 min read
Press Releases
Colossal Advances Dodo De-Extinction with Significant, World’s First Breakthrough in Pigeon PGCs and Secures an Additional $120M in Funding for Species Expansion
September 18, 2025
·
14 min read
Lone Star Bio
Revolutionary Elephant iPSC Milestone Reached in Colossal’s Woolly Mammoth Project
Colossal Biosciences, the world’s first de-extinction company, announces that their Woolly Mammoth team has achieved a global-first iPSC breakthrough.
March 6, 2024
·
6 min read
Lone Star Bio
Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll
Scientists from Colossal Biosciences, the world’s first de-extinction company, and the University of Melbourne announce a major step forward in the effort to save Australia’s endangered northern quoll from the invasive cane toad.
May 8, 2024
·
9 min read
Press Releases
Colossal Creates the Colossal Woolly Mouse, Showcasing Breakthroughs in Multiplex Genome Editing and Trait Engineering on the Path to a Mammoth
March 5, 2025
·
6 min read
Lone Star Bio
Colossal Announces the Tasmania Thylacine Advisory Committee
Colossal Biosciences, the breakthrough genetic engineering and de-extinction company, is pleased to announce the formation of the Tasmania Thylacine Advisory Committee.
December 20, 2023
·
4 min read
Lone Star Bio
Colossal Biosciences Joins BioRescue in Its Mission to Save the Northern White Rhino From Extinction
Colossal Biosciences, the world’s first de-extinction company, and BioRescue, a consortium initiating and leading the scientific rescue mission of the northern white rhino employing advanced assisted reproduction technologies and stem cell associated techniques, have teamed up to save the northern white rhino from extinction.
September 19, 2023
·
9 min read
Lone Star Bio
Colossal Biosciences and the Vertebrate Genomes Project Publish the First Near Complete African Elephant Chromosome Level Genome
Colossal Biosciences, a breakthrough biosciences and genetic engineering company, and the Vertebrate Genomes Project, which aims to sequence high-quality reference genomes for all living vertebrates, partnered to successfully generate the first high-quality reference genome of the African elephant.
May 18, 2023
·
6 min read
GLP-1
Lilly, Novo Skew Overall Pharma Trends With Colossal GLP-1 Sales Growth
From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved into a new pharma stratosphere, far eclipsing their rivals.
February 12, 2025
·
2 min read
·
Annalee Armstrong
1 of 4,019
Next
